Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.
J Immunother Cancer
; 10(11)2022 11.
Article
in En
| MEDLINE
| ID: mdl-36328378
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Head and Neck Neoplasms
/
Metformin
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2022
Document type:
Article
Affiliation country: